COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery /The Egyptian Journal of Neurology, Psychiatry and Neurosurgery